Shukra Pharmaceuticals Capital Structure Change
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
- Value
- ₹4.63 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Shukra Pharmaceuticals allotted 17.35 lakh equity shares upon warrant conversion to promoters. The exercise raised Rs. 4.63 Crore, increasing the paid-up capital.
Shukra Pharmaceuticals allotted 11,73,000 equity shares following the conversion of warrants, generating Rs.3.13 Crore in exercise proceeds. This allotment increases the company's paid-up equity capital.
Shukra Pharmaceuticals confirmed receipt of Rs. 0.38 Crore differential consideration for 46.43 lakh warrants. The price was revised from Rs. 34.00 to Rs. 35.56 per warrant.